Devices Inc. (Nasdaq: MASS) and Getinge announce their collaboration to integrate Getinge’s bioreactors with 908 Devices’ MAVEN for automated control of glucose and lactate levels in cell cultures.

As 2025 approaches, what technologies, from robotics to AI, are agrifoodtech startups keeping watching? Elaine Watson fired ...

Recent advances in disease modeling have highlighted the urgent need for culture systems that closely mimic the complexity ...

By monitoring critical metabolic parameters, a path can be mapped out to create golden batches, which meet or exceed all of ...

The world loves chocolate, but the planet? Not so much. These 11 startups are changing that with cocoa-free and cell-based ...

Cultured meat technology addresses environmental and public health issues, offering a viable solution to meat production with ...

The global cell culture market is estimated to flourish at a CAGR of 9% from 2021 to 2031. Transparency Market Research projects that the overall sales revenue for cell culture is estimated to reach ...

A cell culture is defined as the distribution of cells in an artificial environment (in vitro). Furthermore, this artificial environment is composed of all the necessary nutrients such as ideal ...

Cocoa-tech startup Celleste Bio raises $4.5 million, including from Mondelz's SnackFutures Ventures and Supply Change Capital ...

The sickle cell gene therapies developed by Bluebird Bio and Vertex will be the first to be offered under the new scheme. A major issue with gene and cell therapies is the upfront cost. While these ...